Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085717/0/en/BioCardia-to-Participate-in-Fireside-Chat-at-A-G-P-Virtual-Healthcare-Company-Showcase-on-May-21-2025.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081581/0/en/BioCardia-Reports-First-Quarter-2025-Business-Highlights-and-Financial-Results.html
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078541/0/en/BioCardia-to-Host-Q1-2025-Corporate-Update-and-Financial-Results-Conference-Call-on-May-14-2025.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074998/0/en/BioCardia-Initiates-Patient-Enrollment-at-University-of-Wisconsin-at-Madison-for-Ongoing-CardiAMP-HF-II-Pivotal-Study.html
01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072465/0/en/BioCardia-Announces-First-Patient-in-Phase-3-Randomized-Controlled-Double-Blind-CardiAMP-HF-II-Clinical-Trial-of-the-Company-s-Lead-Cell-Therapy-for-Treatment-of-Heart-Failure.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3061732/0/en/BioCardia-Announces-Positive-DSMB-Review-of-CardiALLO-Allogeneic-Cell-Therapy-for-Heart-Failure-Phase-1-2-Clinical-Trial.html
ABOUT THIS PAGE